Kaken Pharmaceutical Co.

Kaken Pharmaceutical Co. Overview

Status Public
Employees 1,603
Stock Symbol 4521
Stock Symbol
Share Price $53.53 (As of Thursday Closing)

Kaken Pharmaceutical Co. General Information


Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • Tokyo
  • Japan
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kaken Pharmaceutical Co. Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$53.53 $54.93 $36.36 - $60.35 $2.09B 39M 218K $4.45

Kaken Pharmaceutical Co. Financials Summary

In Thousands,
TTM 31-Dec-2019 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018 FY 2017 31-Mar-2017
EV 1,590,326 1,372,480 2,020,443 2,065,188
Revenue 841,650 849,322 887,951 941,297
EBITDA 244,297 269,014 304,989
Net Income 175,024 160,318 171,786 203,200
Total Assets 1,474,331 1,406,798 1,434,244 1,207,977
Total Debt 35,584 34,948 36,464 34,658
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ready to get started?

Request a free trial